![Surgical & Cosmetic Dermatology | Extensive basal cell carcinoma responsive to Imiquimod: a thirty-six-month follow up Surgical & Cosmetic Dermatology | Extensive basal cell carcinoma responsive to Imiquimod: a thirty-six-month follow up](http://www.surgicalcosmetic.org.br/content/imagebank/figuras_i/en_v7n3a14-fig01.jpg)
Surgical & Cosmetic Dermatology | Extensive basal cell carcinoma responsive to Imiquimod: a thirty-six-month follow up
![Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_CT095020020-e_Fig2B.jpg.jpg)
Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology
![How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/intraepidermal-carcinoma.jpg)
How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand
![Frontiers | Clinical and Dermoscopic Factors for the Identification of Aggressive Histologic Subtypes of Basal Cell Carcinoma Frontiers | Clinical and Dermoscopic Factors for the Identification of Aggressive Histologic Subtypes of Basal Cell Carcinoma](https://www.frontiersin.org/files/Articles/630458/fonc-10-630458-HTML/image_m/fonc-10-630458-g001.jpg)
Frontiers | Clinical and Dermoscopic Factors for the Identification of Aggressive Histologic Subtypes of Basal Cell Carcinoma
![Cryosurgery During Imiquimod Cream Treatment ("Immunocryosurgery") for Bowen's Disease of the Skin: A Case Series | HTML | Acta Dermato-Venereologica Cryosurgery During Imiquimod Cream Treatment ("Immunocryosurgery") for Bowen's Disease of the Skin: A Case Series | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/content_files/files/web/3249-web-images/3249fig1_opt.jpeg)
Cryosurgery During Imiquimod Cream Treatment ("Immunocryosurgery") for Bowen's Disease of the Skin: A Case Series | HTML | Acta Dermato-Venereologica
![Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial | BMC Ophthalmology | Full Text Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial | BMC Ophthalmology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12886-015-0024-0/MediaObjects/12886_2015_24_Fig2_HTML.gif)
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial | BMC Ophthalmology | Full Text
![How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/imiquimod-aks-mild.jpg)
How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand
![Surgery vs imiquimod for nodular and superficial basal cell carcinoma (SINS) - The University of Nottingham Surgery vs imiquimod for nodular and superficial basal cell carcinoma (SINS) - The University of Nottingham](https://www.nottingham.ac.uk/Research/Groups/cebd/Images-Multimedia/BCC340x254.jpg)
Surgery vs imiquimod for nodular and superficial basal cell carcinoma (SINS) - The University of Nottingham
![Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/styles/teaser_opengraph/public/images/article_teasers/CT095020020-e_fig1_carousel.jpg)
Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology
![Imiquimod in the treatment of eyelid basal cell carcinoma - Leppälä - 2007 - Acta Ophthalmologica Scandinavica - Wiley Online Library Imiquimod in the treatment of eyelid basal cell carcinoma - Leppälä - 2007 - Acta Ophthalmologica Scandinavica - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6a2a5914-a3ca-4390-af9c-69f314b766e5/aos_896_f1.gif)
Imiquimod in the treatment of eyelid basal cell carcinoma - Leppälä - 2007 - Acta Ophthalmologica Scandinavica - Wiley Online Library
![Oral Acitretin and Topical Imiquimod as Neoadjuvant Treatment for Giant Basal Cell Carcinoma - ScienceDirect Oral Acitretin and Topical Imiquimod as Neoadjuvant Treatment for Giant Basal Cell Carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1578219012000625-gr1.jpg)
Oral Acitretin and Topical Imiquimod as Neoadjuvant Treatment for Giant Basal Cell Carcinoma - ScienceDirect
![Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_CT095020020-e_Fig1.jpg.jpg)
Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology
![Oral Acitretin and Topical Imiquimod as Neoadjuvant Treatment for Giant Basal Cell Carcinoma - ScienceDirect Oral Acitretin and Topical Imiquimod as Neoadjuvant Treatment for Giant Basal Cell Carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1578219012000625-gr2.jpg)